Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Chronic disease prevention and management programs in primary care: Realist synthesis of 6 programs in Quebec.

Ramond-Roquin A, Chouinard MC, Diallo BB, Bouhali T, Provost S, Fortin M.

Can Fam Physician. 2019 Aug;65(8):559-566.

2.

Deciphering the potential involvement of PXMP2 and PEX11B in hydrogen peroxide permeation across the peroxisomal membrane reveals a role for PEX11B in protein sorting.

Lismont C, Koster J, Provost S, Baes M, Van Veldhoven PP, Waterham HR, Fransen M.

Biochim Biophys Acta Biomembr. 2019 Oct 1;1861(10):182991. doi: 10.1016/j.bbamem.2019.05.013. Epub 2019 May 24.

PMID:
31129117
3.

'A match made in midwifery': Women's perceptions of student midwife partnerships.

Jefford E, Nolan SJ, Sansone H, Provost SC.

Women Birth. 2018 Dec 13. pii: S1871-5192(18)30649-8. doi: 10.1016/j.wombi.2018.11.018. [Epub ahead of print]

PMID:
30554958
4.

Focus Group Study to Examine Content of Family Meetings in Short-term Substance Use Disorder Treatment.

Faberman J, Provost SE, Weiss RD, Greenfield SF.

J Soc Work Pract Addict. 2018;18(3):231-248. doi: 10.1080/1533256X.2018.1488720. Epub 2018 Jul 11.

5.

Envisioning successful teamwork: An exploratory qualitative study of team processes used by nursing teams in a paediatric hospital unit.

Whitehair L, Hurley J, Provost S.

J Clin Nurs. 2018 Dec;27(23-24):4257-4269. doi: 10.1111/jocn.14558. Epub 2018 Jul 23.

PMID:
29893436
6.

Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A.

Buscarlet M, Provost S, Zada YF, Bourgoin V, Mollica L, Dubé MP, Busque L.

Blood. 2018 Jul 19;132(3):277-280. doi: 10.1182/blood-2018-01-829937. Epub 2018 May 15.

7.

A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure.

de Denus S, Dubé MP, Fouodjio R, Huynh T, LeBlanc MH, Lepage S, Sheppard R, Giannetti N, Lavoie J, Mansour A, Provost S, Normand V, Mongrain I, Langlois M, O'Meara E, Ducharme A, Racine N, Guertin MC, Turgeon J, Phillips MS, Rouleau JL, Tardif JC, White M; CANDIID II investigators.

Pharmacogenomics. 2018 May;19(7):599-612. doi: 10.2217/pgs-2018-0004. Epub 2018 Apr 27.

PMID:
29701105
8.

Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.

Perreault S, Shahabi P, Côté R, Dumas S, Rouleau-Mailloux É, Feroz Zada Y, Provost S, Mongrain I, Dorais M, Huynh T, Kouz S, Diaz A, Blostein M, de Denus S, Turgeon J, Ginsberg J, Lelorier J, Lalonde L, Busque L, Kassis J, Talajic M, Tardif JC, Dubé MP.

Clin Cardiol. 2018 May;41(5):576-585. doi: 10.1002/clc.22948. Epub 2018 May 15.

9.

Effects on patients of variations in the implementation of a cardiometabolic risk intervention program in Montréal.

Beauregard MÈ, Provost S, Pineault R, Grimard D, Pérez J, Fournier M.

Health Promot Chronic Dis Prev Can. 2018 Feb;38(2):64-77. doi: 10.24095/hpcdp.38.2.03. English, French.

10.

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort.

Shahabi P, Lamothe F, Dumas S, Rouleau-Mailloux É, Feroz Zada Y, Provost S, Asselin G, Mongrain I, Valois D, Gaulin Marion MJ, Lemieux Perreault LP, Perreault S, Dubé MP.

Pharmacogenomics J. 2019 Apr;19(2):147-156. doi: 10.1038/s41397-017-0005-1. Epub 2018 Jan 3.

11.

Identification of the genetic determinants responsible for retinal degeneration in families of Mexican descent.

Villanueva A, Biswas P, Kishaba K, Suk J, Tadimeti K, Raghavendra PB, Nadeau K, Lamontagne B, Busque L, Geoffroy S, Mongrain I, Asselin G, Provost S, Dubé MP, Nudleman E, Ayyagari R.

Ophthalmic Genet. 2018 Jan-Feb;39(1):73-79. doi: 10.1080/13816810.2017.1373830. Epub 2017 Sep 25.

12.

What can organizations do to improve family physicians' interprofessional collaboration? Results of a survey of primary care in Quebec.

Perreault K, Pineault R, Da Silva RB, Provost S, Feldman DE.

Can Fam Physician. 2017 Sep;63(9):e381-e388.

13.

Explaining time elapsed prior to cancer diagnosis: patients' perspectives.

Brousselle A, Breton M, Benhadj L, Tremblay D, Provost S, Roberge D, Pineault R, Tousignant P.

BMC Health Serv Res. 2017 Jun 28;17(1):448. doi: 10.1186/s12913-017-2390-1.

14.

DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions.

Buscarlet M, Provost S, Zada YF, Barhdadi A, Bourgoin V, Lépine G, Mollica L, Szuber N, Dubé MP, Busque L.

Blood. 2017 Aug 10;130(6):753-762. doi: 10.1182/blood-2017-04-777029. Epub 2017 Jun 27.

15.

Do Gender-Predominant Primary Health Care Organizations Have an Impact on Patient Experience of Care, Use of Services, and Unmet Needs?

Pineault R, Borgès Da Silva R, Provost S, Fournier M, Prud'homme A, Levesque JF.

Inquiry. 2017 Jan 1;54:46958017709688. doi: 10.1177/0046958017709688.

16.

Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrol.

Rivollier F, Chaumette B, Bendjemaa N, Chayet M, Millet B, Jaafari N, Barhdadi A, Lemieux Perreault LP, Provost S, Dubé MP, Gaillard R, Krebs MO, Kebir O.

PLoS One. 2017 Apr 13;12(4):e0174783. doi: 10.1371/journal.pone.0174783. eCollection 2017.

17.

Implementation of an integrated primary care cardiometabolic risk prevention and management network in Montréal: does greater coordination of care with primary care physicians have an impact on health outcomes?

Provost S, Pineault R, Grimard D, Pérez J, Fournier M, Lévesque Y, Desforges J, Tousignant P, Borgès Da Silva R.

Health Promot Chronic Dis Prev Can. 2017 Apr;37(4):105-113. doi: 10.24095/hpcdp.37.4.01. English, French.

18.

Team-based innovations in primary care delivery in Quebec and timely physician follow-up after hospital discharge: a population-based cohort study.

Riverin BD, Li P, Naimi AI, Diop M, Provost S, Strumpf E.

CMAJ Open. 2017 Jan 13;5(1):E28-E35. doi: 10.9778/cmajo.20160059. eCollection 2017 Jan-Mar.

19.

Does enrollment in multidisciplinary team-based primary care practice improve adherence to guideline-recommended processes of care? Quebec's Family Medicine Groups, 2002-2010.

Diop M, Fiset-Laniel J, Provost S, Tousignant P, Borgès Da Silva R, Ouimet MJ, Latimer E, Strumpf E.

Health Policy. 2017 Apr;121(4):378-388. doi: 10.1016/j.healthpol.2017.02.001. Epub 2017 Feb 13.

PMID:
28233598
20.

Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease.

Webb TR, Erdmann J, Stirrups KE, Stitziel NO, Masca NG, Jansen H, Kanoni S, Nelson CP, Ferrario PG, König IR, Eicher JD, Johnson AD, Hamby SE, Betsholtz C, Ruusalepp A, Franzén O, Schadt EE, Björkegren JL, Weeke PE, Auer PL, Schick UM, Lu Y, Zhang H, Dube MP, Goel A, Farrall M, Peloso GM, Won HH, Do R, van Iperen E, Kruppa J, Mahajan A, Scott RA, Willenborg C, Braund PS, van Capelleveen JC, Doney AS, Donnelly LA, Asselta R, Merlini PA, Duga S, Marziliano N, Denny JC, Shaffer C, El-Mokhtari NE, Franke A, Heilmann S, Hengstenberg C, Hoffmann P, Holmen OL, Hveem K, Jansson JH, Jöckel KH, Kessler T, Kriebel J, Laugwitz KL, Marouli E, Martinelli N, McCarthy MI, Van Zuydam NR, Meisinger C, Esko T, Mihailov E, Escher SA, Alver M, Moebus S, Morris AD, Virtamo J, Nikpay M, Olivieri O, Provost S, AlQarawi A, Robertson NR, Akinsansya KO, Reilly DF, Vogt TF, Yin W, Asselbergs FW, Kooperberg C, Jackson RD, Stahl E, Müller-Nurasyid M, Strauch K, Varga TV, Waldenberger M; Wellcome Trust Case Control Consortium, Zeng L, Chowdhury R, Salomaa V, Ford I, Jukema JW, Amouyel P, Kontto J; MORGAM Investigators, Nordestgaard BG, Ferrières J, Saleheen D, Sattar N, Surendran P, Wagner A, Young R, Howson JM, Butterworth AS, Danesh J, Ardissino D, Bottinger EP, Erbel R, Franks PW, Girelli D, Hall AS, Hovingh GK, Kastrati A, Lieb W, Meitinger T, Kraus WE, Shah SH, McPherson R, Orho-Melander M, Melander O, Metspalu A, Palmer CN, Peters A, Rader DJ, Reilly MP, Loos RJ, Reiner AP, Roden DM, Tardif JC, Thompson JR, Wareham NJ, Watkins H, Willer CJ, Samani NJ, Schunkert H, Deloukas P, Kathiresan S; Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators.

J Am Coll Cardiol. 2017 Feb 21;69(7):823-836. doi: 10.1016/j.jacc.2016.11.056.

21.

Human blood cell levels of 5-hydroxymethylcytosine (5hmC) decline with age, partly related to acquired mutations in TET2.

Buscarlet M, Tessier A, Provost S, Mollica L, Busque L.

Exp Hematol. 2016 Nov;44(11):1072-1084. doi: 10.1016/j.exphem.2016.07.009. Epub 2016 Jul 27.

PMID:
27475703
22.

Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical Outcomes.

Tardif JC, Rhainds D, Brodeur M, Feroz Zada Y, Fouodjio R, Provost S, Boulé M, Alem S, Grégoire JC, L'Allier PL, Ibrahim R, Guertin MC, Mongrain I, Olsson AG, Schwartz GG, Rhéaume E, Dubé MP.

Circ Cardiovasc Genet. 2016 Aug;9(4):340-8. doi: 10.1161/CIRCGENETICS.116.001405. Epub 2016 Jul 14.

23.

Whole-genome sequencing in French Canadians from Quebec.

Low-Kam C, Rhainds D, Lo KS, Provost S, Mongrain I, Dubois A, Perreault S, Robinson JF, Hegele RA, Dubé MP, Tardif JC, Lettre G.

Hum Genet. 2016 Nov;135(11):1213-1221. Epub 2016 Jul 4.

PMID:
27376640
24.

DNA methylation signature of human fetal alcohol spectrum disorder.

Portales-Casamar E, Lussier AA, Jones MJ, MacIsaac JL, Edgar RD, Mah SM, Barhdadi A, Provost S, Lemieux-Perreault LP, Cynader MS, Chudley AE, Dubé MP, Reynolds JN, Pavlidis P, Kobor MS.

Epigenetics Chromatin. 2016 Jun 29;9:25. doi: 10.1186/s13072-016-0074-4. eCollection 2016.

25.

Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users.

Dumas S, Rouleau-Mailloux E, Bouchama N, Lahcene H, Talajic M, Tardif JC, Gaulin MJ, Provost S, Dubé MP, Perreault S.

J Manag Care Spec Pharm. 2016 Jun;22(6):676-84. doi: 10.18553/jmcp.2016.22.6.676.

26.

Evolution of Experience of Care of Patients with and without Chronic Diseases following a Québec Primary Healthcare Reform.

Pineault R, Borgès Da Silva R, Provost S, Breton M, Tousignant P, Fournier M, Prud'homme A, Levesque JF.

Int J Chronic Dis. 2016;2016:2497637. doi: 10.1155/2016/2497637. Epub 2016 Apr 7.

27.

Methylomic changes during conversion to psychosis.

Kebir O, Chaumette B, Rivollier F, Miozzo F, Lemieux Perreault LP, Barhdadi A, Provost S, Plaze M, Bourgin J; ICAAR team, Gaillard R, Mezger V, Dubé MP, Krebs MO.

Mol Psychiatry. 2017 Apr;22(4):512-518. doi: 10.1038/mp.2016.53. Epub 2016 Apr 26.

28.

Impacts of Québec Primary Healthcare Reforms on Patients' Experience of Care, Unmet Needs, and Use of Services.

Pineault R, Borgès Da Silva R, Provost S, Breton M, Tousignant P, Fournier M, Prud'homme A, Levesque JF.

Int J Family Med. 2016;2016:8938420. doi: 10.1155/2016/8938420. Epub 2016 Feb 10.

29.

A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.

de Denus S, Rouleau JL, Mann DL, Huggins GS, Cappola TP, Shah SH, Keleti J, Zada YF, Provost S, Bardhadi A, Phillips MS, Normand V, Mongrain I, Dubé MP.

Pharmacogenomics J. 2017 Mar;17(2):192-200. doi: 10.1038/tpj.2016.4. Epub 2016 Mar 1.

30.

Why Is Bigger Not Always Better in Primary Health Care Practices? The Role of Mediating Organizational Factors.

Pineault R, Provost S, Borgès Da Silva R, Breton M, Levesque JF.

Inquiry. 2016 Jan 31;53. pii: 0046958015626842. doi: 10.1177/0046958015626842. Print 2016.

31.

The impact of primary healthcare reform on equity of utilization of services in the province of Quebec: a 2003-2010 follow-up.

Ouimet MJ, Pineault R, Prud'homme A, Provost S, Fournier M, Levesque JF.

Int J Equity Health. 2015 Nov 30;14:139. doi: 10.1186/s12939-015-0243-2.

32.

Does the Primary Care Experience Influence the Cancer Diagnostic Process?

Provost S, Pineault R, Tousignant P, Roberge D, Tremblay D, Breton M, Benhadj L, Diop M, Fournier M, Brousselle A.

Int J Family Med. 2015;2015:176812. doi: 10.1155/2015/176812. Epub 2015 Oct 4.

33.

The prevention and management of chronic disease in primary care: recommendations from a knowledge translation meeting.

Ahmed S, Ware P, Visca R, Bareil C, Chouinard MC, Desforges J, Finlayson R, Fortin M, Gauthier J, Grimard D, Guay M, Hudon C, Lalonde L, Lévesque L, Michaud C, Provost S, Sutton T, Tousignant P, Travers S, Ware M, Gogovor A.

BMC Res Notes. 2015 Oct 15;8:571. doi: 10.1186/s13104-015-1514-0.

34.

Les nouvelles formes d’organisations de soins de santé primaires (OSSP) sont-elles associées à une meilleure expérience de soins chez les patients atteints de maladies chroniques au Québec'.

Pineault R, Da Silva RB, Provost S, Fournier M, Prud Homme A.

Sante Publique. 2015 Mar-Apr;1 Suppl:119-28. French. No abstract available.

PMID:
26414265
35.

An Algorithm Using Administrative Data to Identify Patient Attachment to a Family Physician.

Provost S, Pérez J, Pineault R, Borgès Da Silva R, Tousignant P.

Int J Family Med. 2015;2015:967230. doi: 10.1155/2015/967230. Epub 2015 Aug 27.

36.

Impact of regular physical activity on weekly warfarin dose requirement.

Rouleau-Mailloux É, Shahabi P, Dumas S, Feroz Zada Y, Provost S, Hu J, Nguyen J, Bouchama N, Mongrain I, Talajic M, Tardif JC, Perreault S, Dubé MP.

J Thromb Thrombolysis. 2016 Feb;41(2):328-35. doi: 10.1007/s11239-015-1248-9.

37.

[Are new forms of primary health care organization (PHLU) associated with a better health care experience for patients with chronic diseases in Quebec?].

Pineault R, Da Silva RB, Provost S, Fournier M, Prud'homme A.

Sante Publique. 2015 Jan-Feb;27(1 Suppl):S119-28. French.

PMID:
26168625
38.

[Congenital myasthenic syndromes in childhood: Drug therapeutic strategies].

de la Vaissière S, Toutain A, Chêne MA, Lagrue E, Cantagrel S, Provost S, Eymard B, Castelnau P.

Arch Pediatr. 2015 Jul;22(7):724-8. doi: 10.1016/j.arcped.2015.04.009. Epub 2015 May 28. Review. French.

PMID:
26028221
39.

Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.

Weiss RD, Potter JS, Griffin ML, Provost SE, Fitzmaurice GM, McDermott KA, Srisarajivakul EN, Dodd DR, Dreifuss JA, McHugh RK, Carroll KM.

Drug Alcohol Depend. 2015 May 1;150:112-9. doi: 10.1016/j.drugalcdep.2015.02.030. Epub 2015 Mar 6.

40.

Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study.

Griffin ML, Bennett HE, Fitzmaurice GM, Hill KP, Provost SE, Weiss RD.

Am J Addict. 2015 Jun;24(4):308-14. doi: 10.1111/ajad.12188. Epub 2015 Mar 24.

41.

Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib.

Tardif JC, Rhéaume E, Lemieux Perreault LP, Grégoire JC, Feroz Zada Y, Asselin G, Provost S, Barhdadi A, Rhainds D, L'Allier PL, Ibrahim R, Upmanyu R, Niesor EJ, Benghozi R, Suchankova G, Laghrissi-Thode F, Guertin MC, Olsson AG, Mongrain I, Schwartz GG, Dubé MP.

Circ Cardiovasc Genet. 2015 Apr;8(2):372-82. doi: 10.1161/CIRCGENETICS.114.000663. Epub 2015 Jan 11.

PMID:
25583994
42.

Improving outcomes of hospitalized patients: the Physician Relationships, Improvising, and Sensemaking intervention protocol.

Leykum LK, Lanham HJ, Provost SM, McDaniel RR, Pugh J.

Implement Sci. 2014 Nov 26;9:171. doi: 10.1186/s13012-014-0171-3.

43.

CKM and LILRB5 are associated with serum levels of creatine kinase.

Dubé MP, Zetler R, Barhdadi A, Brown AM, Mongrain I, Normand V, Laplante N, Asselin G, Zada YF, Provost S, Bergeron J, Kouz S, Dufour R, Diaz A, de Denus S, Turgeon J, Rhéaume E, Phillips MS, Tardif JC.

Circ Cardiovasc Genet. 2014 Dec;7(6):880-6. doi: 10.1161/CIRCGENETICS.113.000395. Epub 2014 Sep 11.

PMID:
25214527
44.

The multi-site prescription opioid addiction treatment study: 18-month outcomes.

Potter JS, Dreifuss JA, Marino EN, Provost SE, Dodd DR, Rice LS, Fitzmaurice GM, Griffin ML, Weiss RD.

J Subst Abuse Treat. 2015 Jan;48(1):62-9. doi: 10.1016/j.jsat.2014.07.009. Epub 2014 Aug 2.

45.

Modifiers of (CAG)(n) instability in Machado-Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes.

Martins S, Pearson CE, Coutinho P, Provost S, Amorim A, Dubé MP, Sequeiros J, Rouleau GA.

Hum Genet. 2014 Oct;133(10):1311-8. doi: 10.1007/s00439-014-1467-8. Epub 2014 Jul 16.

PMID:
25026993
46.

Impact of Québec's healthcare reforms on the organization of primary healthcare (PHC): a 2003-2010 follow-up.

Pineault R, Borgès Da Silva R, Prud'homme A, Fournier M, Couture A, Provost S, Levesque JF.

BMC Health Serv Res. 2014 May 21;14:229. doi: 10.1186/1472-6963-14-229.

47.

Dusted community: piloting a virtual peer-to-peer support community for people with an asbestos-related diagnosis and their families.

Kozlowski D, Provost SC, Tucker J, van der Zwan R.

J Psychosoc Oncol. 2014;32(4):463-75. doi: 10.1080/07347332.2014.917142.

PMID:
24794734
48.

Health care huddles: managing complexity to achieve high reliability.

Provost SM, Lanham HJ, Leykum LK, McDaniel RR Jr, Pugh J.

Health Care Manage Rev. 2015 Jan-Mar;40(1):2-12. doi: 10.1097/HMR.0000000000000009.

PMID:
24589926
49.

Comparison of genotype clustering tools with rare variants.

Perreault LP, Legault MA, Barhdadi A, Provost S, Normand V, Tardif JC, Dubé MP.

BMC Bioinformatics. 2014 Feb 21;15:52. doi: 10.1186/1471-2105-15-52.

50.

Primary healthcare solo practices: homogeneous or heterogeneous?

Pineault R, Borgès Da Silva R, Provost S, Beaulieu MD, Boivin A, Couture A, Prud'homme A.

Int J Family Med. 2014;2014:373725. doi: 10.1155/2014/373725. Epub 2014 Jan 12.

Supplemental Content

Loading ...
Support Center